Your Cat May Share the Same Cancer Genes as You, and Offer Clues for Treatment
discovermagazine - Learn how cats and humans can share key cancer mutations — and why those similarities could guide future treatment research.
AI Summary: A comparative genomics study finds the household cat shares key cancer mutations with humans across several tumor types, offering a practical animal model for understanding tumor biology and testing therapies. Researchers suggest these feline-human parallels could accelerate translational oncology for both species, turning a once-dismissed pet anecdote into useful science.
6 months / discovermagazine
What to Expect at the World Cancer Congress 2026 – UICC
oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “The preliminary program for the World Cancer Congress 2026 – taking place in Hong Kong and hosted by UICC […]
AI Summary: The Union for International Cancer Control released the preliminary program for World Cancer Congress 2026, outlining sessions on prevention, equity, innovation and global collaboration. The meeting will assemble policymakers, clinicians and advocates to debate strategy and share research—expect plenaries, networking and ambitious goals paired with painfully realistic budgets.
- Cutting-edge research: enzymes, AI, biomarkers transforming cancer care (23)
- Global oncology meetings: convening leaders and reviewers worldwide (14)
- Other: market, jobs, commentary, and patient communication (9)
- Previewing World Cancer Congress 2026: program, goals, real budgets (1)
- All Other Stories
Cutting-edge research: enzymes, AI, biomarkers transforming cancer care
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / esmo
6 months / nature
6 months / nature
Global oncology meetings: convening leaders and reviewers worldwide
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
Other: market, jobs, commentary, and patient communication
6 months / oncodaily
6 months / oncodaily
6 months / endpoints / Shelby Livingston
Previewing World Cancer Congress 2026: program, goals, real budgets
All Other Stories
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / cancerresearchuk / Fiona MacLeod
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / esmo
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / nature / Marcus Westerberg
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / cancerresearchuk / Cancer Research UK
6 months / esmo
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / medicalxpress
6 months / oncodaily
6 months / medicalxpress
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / endpoints / Jared Whitlock
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / esmo
6 months / oncodaily
6 months / nature
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / beckershospitalreview / Andrew Cass
6 months / oncodaily
6 months / beckershospitalreview / Ella Jeffries
6 months / medicalxpress
6 months / beckershospitalreview / Ella Jeffries
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / oncodaily
6 months / esmo
6 months / cancerresearchuk / Krishna Sharma
6 months / nature
6 months / nature
6 months / nature
6 months / aacr / Neha J. Pancholi, PhD
New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer
discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.
AI Summary: The FDA approved a wearable device that delivers alternating electric fields to disrupt pancreatic tumor growth, letting patients remain ambulatory while receiving treatment. Clinicians hail the noninvasive approach as a new adjunct to standard care, aiming to slow progression in a cancer that’s notoriously hard to treat — and yes, it literally plugs into hope.
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / medicalxpress
6 months / oncodaily
6 months / oncodaily